Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Bernard Cimon is active.

Publication


Featured researches published by Bernard Cimon.


Journal of Clinical Microbiology | 2002

Genotyping Study of Scedosporium apiospermum Isolates from Patients with Cystic Fibrosis

Alain Defontaine; Rachid Zouhair; Bernard Cimon; Jacqueline Carrère; Eric Bailly; Françoise Symoens; Mohammed Diouri; Jean-Noel Hallet; Jean-Philippe Bouchara

ABSTRACT Usually a saprophyte, Scedosporium apiospermum often colonizes the respiratory tracts of patients with cystic fibrosis (CF). In order to improve our understanding of the molecular epidemiology of the airway colonization, 129 sequential and multiple isolates collected from January 1998 to March 1999 from nine CF patients monitored in three hospitals in France were typed by random amplification of polymorphic DNA with primers GC70, UBC-701, and UBC-703. Among these primers, UBC-703 was the most discriminating, allowing the differentiation of 14 genotypes. Combining the results obtained with this three-primer set resulted in the differentiation of 16 genotypes. No common genotype was found among the different patients, and no clustering according to geographic origin of the isolates was seen. In addition, five of the patients were colonized by a single genotype. The others usually exhibited a predominant genotype accompanied by one or two others, which were found occasionally and were genetically close to the predominant genotype. Thus, our study demonstrates the persistence of the fungus despite antifungal treatments and therefore reinforces the need for the development of new antifungals that are more efficient against this species.


Journal of Medical Microbiology | 2001

Molecular epidemiology of airway colonisation by Aspergillus fumigatus in cystic fibrosis patients.

Bernard Cimon; Françoise Symoens; Rachid Zouhair; Dominique Chabasse; Nicole Nolard; Alain Defontaine; Jean-Philippe Bouchara

A total of 109 sequential and multiple Aspergillus fumigatus isolates corresponding to 41 samples from seven cystic fibrosis (CF) patients was typed by random amplification of polymorphic DNA (RAPD) with the primer NS3 from the fungal ribosomal gene 18S subunit, and by sequence-specific DNA primer (SSDP) analysis. RAPD typing of the isolates revealed 10 different genotypes, whereas nine genotypes were identified by SSDP. Combination of the two typing methods permitted the differentiation of 25 overall genotypes. The colonisation typing patterns differed greatly between patients colonised for <1 year by A. fumigatus and long-term colonised patients. Two of three recently colonised patients presented a large number of types even in the same sample, unlike the chronically colonised patients, who harboured a limited number of genotypes. In the latter, the occurrence of a dominant genotype, usually the overall genotype 2, tended to reflect to the duration of colonisation. Moreover, anti-catalase antibodies to A. fumigatus appeared in most cases to be in response to genotype 2. These findings suggest that some strains of A. fumigatus may be selected during prolonged colonisation of the airways in CF patients.


Clinical and Vaccine Immunology | 2013

Comparison of Four Commercially Available Avidity Tests for Toxoplasma gondii-Specific IgG Antibodies

Odile Villard; L. Breit; Bernard Cimon; Jacqueline Franck; Hélène Fricker-Hidalgo; N. Godineau; Sandrine Houzé; L. Paris; Hervé Pelloux; Isabelle Villena; Ermanno Candolfi

ABSTRACT Toxoplasma infection in pregnant women may cause congenital toxoplasmosis. Diagnosis of infection is based on serological tests aimed at detecting IgM and IgG antibodies against Toxoplasma gondii. However, IgM antibodies are not an accurate marker for discriminating between acute and latent infection. Detection of residual or persistent IgM may occur months or even years after primary infection, while the IgG avidity test is a rapid means of identifying latent infections in pregnant women who exhibit both IgG and IgM anti-Toxoplasma antibodies on initial testing during pregnancy. In this study, we assessed and compared the performances of four commercially available Toxoplasma IgG avidity tests in immunocompetent and immunocompromised patients with acute and latent toxoplasmosis. The positive predictive value of high avidity to confirm latent toxoplasmosis was 100% for all the assays, indicating that high avidity is a hallmark of latent infection. However, the negative predictive value of high avidity ranged from 99.2% (bioMérieux) to 95.3% (Abbott), indicating that acute toxoplasmosis could not be reliably diagnosed based on low IgG avidity alone. Thus, the avidity test provides a rapid means for identifying latent Toxoplasma infection in immunocompetent pregnant women presenting both IgG and IgM anti-Toxoplasma antibodies on initial testing. In terms of cost-effectiveness, avidity testing is a powerful tool that optimizes screening and follow-up of pregnant women while minimizing the costs of screening by avoiding subsequent costly maternal and fetal investigation and unnecessary treatment. The cheapest assay, Vidas Toxo IgG Avidity, also had the best performance for the diagnosis of latent toxoplasmosis.


Clinical Microbiology and Infection | 1996

Routine use of CHROMagar Candida medium for presumptive identification of Candida yeast species and detection of mixed fungal populations

Jean-Philippe Bouchara; Philippe Declerck; Bernard Cimon; Claire Planchenault; Ludovic de Gentile; Dominique Chabasse

OBJECTIVE: To assess the value of the new differential culture medium CHROMagar Candida for routine investigation of clinical specimens. METHODS: During a whole year, 6150 clinical samples were plated on CHROMagar Candida medium. After incubation, the green colonies were considered to be Candida albicans. The colonies of other colors were identified using Bichrolatex-krusei, or by their assimilation pattern on ID 32C test strips and their morphology on rice cream-agar-Tween. RESULTS: Among the 6150 clinical samples, 1643 were positive for fungi. Aspergillus fumigatus and Geotrichum sp. were the predominant filamentous fungi isolated. Candida albicans was the most common species isolated (1274 of the positive samples; 77.5%), and Candida glabrata was the second most common yeast isolated (174 positive samples; 10.6%). Other yeast species were detected at lower frequencies, mainly Candida tropicalis (3.8%), Candida krusei (2.7%), Saccharomyces cerevisiae (2.7%) and Candida kefyr (2.3%), and 16 samples revealed a lipophilic species, Malassezia furfur. Mixed fungal populations accounted for 14.7% of the positive samples. Two or more yeast species were detected in 206 of the 242 specimens containing mixed fungal populations, and five yeast species were detected in one sample. Additionally, we did not observe significant differences in the isolation of yeasts or filamentous fungi from the 366 samples simultaneously plated on CHROMagar Candida and Sabouraud dextrose agar. Close agreement between the two culture media was observed for 89.9% of these samples. CONCLUSIONS: CHROMagar Candida medium was shown to be extremely helpful in a routine clinical mycology service, facilitating the detection of mixed cultures of yeasts and allowing direct identification of C. albicans, as well as rapid presumptive identification of the other yeasts: C. glabrata, C. tropicalis, C. krusei and S. cerevisiae. This chromogenic medium thus appears to be suitable as a primary culture medium, particularly for the mycologic surveillance of immunocompromised patients.


Journal of Clinical Microbiology | 2005

Airway Colonization by Acrophialophora fusispora in Patients with Cystic Fibrosis

Bernard Cimon; Svetlana Challier; Hugues Beguin; Jacqueline Carrère; Dominique Chabasse; Jean-Philippe Bouchara

ABSTRACT Acrophialophora fusispora is a thermotolerant soil fungus which is very unusual in clinical samples. Here we report four cases of transient or chronic airway colonization by A. fusispora in patients with cystic fibrosis (CF). However, the prevalence of this fungus in CF patients may be underestimated due to the currently poor knowledge of this fungus in most of the medical mycology laboratories. In addition, its clinical importance regarding CF remains to be evaluated.


Thorax | 1996

Pleural effusion and toxocariasis.

T. Jeanfaivre; Bernard Cimon; N. Tolstuchow; L. de Gentile; D. Chabasse; E. Tuchais

The case history is described of a woman who presented with bilateral pleural effusions caused by Toxocara canis infestation. The condition responded rapidly to treatment.


Medical Mycology | 1995

Subcutaneous abscess caused by Pleurophomopsis lignicola Petr: first case

D. Chabasse; C. de Bievre; E. Legrand; Jean-Paul Saint-André; L. de Gentile; Bernard Cimon; Jean-Philippe Bouchara

The dematiaceous coelomycete Pleurophomopsis lignicola Petr. was isolated repeatedly in pure culture from a subcutaneous abscess of the left leg in a farmer undergoing corticosteroid therapy for asthma gravis. To our knowledge, we report the first case involving this fungus as an aetiological agent of subcutaneous phaeohyphomycosis.


Clinical and Vaccine Immunology | 2015

Purification and Characterization of a Mycelial Catalase from Scedosporium boydii, a Useful Tool for Specific Antibody Detection in Patients with Cystic Fibrosis

Sara Mina; Agnes Marot-Leblond; Bernard Cimon; Maxime Fleury; Gérald Larcher; Jean-Philippe Bouchara; Raymond Robert

ABSTRACT Scedosporium boydii is an opportunistic filamentous fungus which may be responsible for a wide variety of infections in immunocompetent and immunocompromised individuals. This fungus belongs to the Scedosporium apiospermum species complex, which usually ranks second among the filamentous fungi colonizing the airways of patients with cystic fibrosis (CF) and may lead to allergic bronchopulmonary mycoses, sensitization, or respiratory infections. Upon microbial infection, host phagocytic cells release reactive oxygen species (ROS), such as hydrogen peroxide, as part of the antimicrobial response. Catalases are known to protect pathogens against ROS by detoxification of the hydrogen peroxide. Here, we investigated the catalase equipment of Scedosporium boydii, one of the major pathogenic species in the S. apiospermum species complex. Three catalases were identified, and the mycelial catalase A1 was purified to homogeneity by a three-step chromatographic process. This enzyme is a monofunctional tetrameric protein of 460 kDa, consisting of four 82-kDa glycosylated subunits. The potential usefulness of this enzyme in serodiagnosis of S. apiospermum infections was then investigated by an enzyme-linked immunosorbent assay (ELISA), using 64 serum samples from CF patients. Whatever the species involved in the S. apiospermum complex, sera from infected patients were clearly differentiated from sera from patients with an Aspergillus fumigatus infection or those from CF patients without clinical and biological signs of a fungal infection and without any fungus recovered from sputum samples. These results suggest that catalase A1 is a good candidate for the development of an immunoassay for serodiagnosis of infections caused by the S. apiospermum complex in patients with CF.


Mycopathologia | 1995

Prevalence ofCandida ciferrii in elderly patients with trophic disorders of the legs

Ludovic de Gentile; Jean-Philippe Bouchara; Christian Le Clec'h; Bernard Cimon; Françoise Symoens; Dominique Chabasse

In order to define the prevalence ofCandida ciferrii in onychomycosis, the fungal biota associated with toe nail onyxis was examined in 50 elderly patients with trophic disorders of the legs and in 220 patients without clinical evidence of trophic disorders.Candida ciferrii was more frequent in the first group of patients since it was recovered from 24% of these patients, whereas its prevalence was only 1.4% in the control group. Moreover, the positivity of the direct examination of toe nail scrapings, the absence of any other associated pathogens, and the repeated isolation of this yeast species for some of the patients confirmed its pathogenicity.


Immuno-analyse & Biologie Specialisee | 2002

Comment résoudre les difficultés du sérodiagnostic de la toxoplasmose chez la femme enceinte

Bernard Cimon; P Penn; Sophie Brun; Dominique Chabasse

Resume La surveillance serologique de la femme enceinte, etape essentielle dans la prevention de la toxoplasmose congenitale, est l’objet de difficultes qui requierent l’utilisation de techniques complementaires mises en œuvre de facon strategique. Ainsi, en presence d’IgG et d’IgM anti-toxoplasmiques chez une femme enceinte, differentes strategies basees sur la confrontation des resultats de plusieurs tests, la detection d’IgA specifiques ou encore la mesure de l’avidite des IgG, permettent d’evaluer le stade evolutif de l’infection toxoplasmique des l’analyse du premier serum. Cette datation doit cependant etre confirmee par un controle serologique a 3 semaines. L’interpretation d’un taux faible d’IgG anti-toxoplasmiques est un autre probleme frequemment rencontre. Elle implique un dosage des IgG par une seconde technique telle que l’agglutination directe haute sensibilite de facon a preciser le statut immunitaire de la patiente. Par ailleurs, la positivite du seul test de detection des IgM peut traduire une toxoplasmose debutante ou une reaction non specifique dans la detection de ce marqueur. La recherche d’IgM par une autre methode et la realisation d’une serologie de controle a court terme apportent ici une bonne orientation diagnostique. Enfin, la determination de l’avidite des IgG peut contribuer a differencier un rebond serologique d’une seroconversion toxoplasmique atypique, sans IgM.

Collaboration


Dive into the Bernard Cimon's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Alain Defontaine

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge